Combinatorial Tuning of Multigene Biosynthetic Pathways based on RNA Interference
- 1State Key Laboratory of Microbial Technology Nanjing Normal University Nanjing People's Republic of China
- 2School of Food Science and Pharmaceutical Engineering Nanjing Normal University Nanjing People's Republic of China
Abstract
Fine‐tuning the expression level of multigene pathways remains a major challenge in engineering eukaryotic microbial cell factories. Modifications to individual pathway genes and CRISPR‐based approaches often require repeated genome reconstruction, large regulatory components, or complex guide‐array assembly. Here, we developed a lightweight, post‐transcriptional RNAi‐based strategy that enables fine‐tuning gene expression without iterative genome editing. Size‐selected small‐RNA sequencing and functional testing were used to identify endogenous Pol III promoters spanning graded transcriptional strengths in Schizochytrium sp. Combining promoter strength with multiple short hairpin RNA (shRNA) target positions expanded the accessible repression range and enabled high‐resolution gene‐dosage tuning. The RNAi‐based combined regulation strategy was applied to the three‐gene carotenoid pathway of Schizochytrium sp. and the nine‐gene docosahexaenoic acid (DHA) pathway of Yarrowia lipolytica, significantly enhancing the product production in both hosts. Integration of RNAi screening and dosage optimization further identified and tuned bypass pathways, increasing the ratio of DHA to docosapentaenoic acid (DPA) by 4.50‐fold versus wild type. These gains were maintained during 5‐L fermentation and serial passaging. This work establishes a compact and scalable regulatory framework for engineering complex biosynthetic pathways in eukaryotic microbial hosts.
Related
- Editorial: Biosynthetic pathways and metabolic engineering of bioactive natural products from medicinal plants
- PrimeStack editors enable efficient and site-specific integration of large multigene cargos in plants
- Engineering the paclitaxel biosynthetic pathway in Physcomitrium patens for de novo and stable biosynthesis
- Dynamic Profiling of Polymethoxyflavones and Biosynthetic Insights in the Peel of Citrus depressa During Fruit Development
- Release of the Staphylococcus aureus autoinducing peptide is enabled by active export of the biosynthetic intermediate
BibTeX
@article{zhang2026combinatorial,
title = {{Combinatorial Tuning of Multigene Biosynthetic Pathways based on RNA Interference}},
author = {Zixu Zhang and Yingshuang Xu and Zijia Li and Fei Du and Wang Ma and Guang Yang and Xiaoman Sun},
journal = {Advanced Science},
year = {2026},
month = nov,
doi = {10.1002/advs.78608},
url = {https://doi.org/10.1002/advs.78608},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Combinatorial Tuning of Multigene Biosynthetic Pathways based on RNA Interference
AU - Zixu Zhang
AU - Yingshuang Xu
AU - Zijia Li
AU - Fei Du
AU - Wang Ma
AU - Guang Yang
AU - Xiaoman Sun
PY - 2026
DA - 2026/11/03
JO - Advanced Science
DO - 10.1002/advs.78608
UR - https://doi.org/10.1002/advs.78608
AB - Fine‐tuning the expression level of multigene pathways remains a major challenge in engineering eukaryotic microbial cell factories. Modifications to individual pathway genes and CRISPR‐based approaches often require repeated genome reconstruction, large regulatory components, or complex guide‐array assembly. Here, we developed a lightweight, post‐transcriptional RNAi‐based strategy that enables fine‐tuning gene expression without iterative genome editing. Size‐selected small‐RNA sequencing and functional testing were used to identify endogenous Pol III promoters spanning graded transcriptional strengths in Schizochytrium sp. Combining promoter strength with multiple short hairpin RNA (shRNA) target positions expanded the accessible repression range and enabled high‐resolution gene‐dosage tuning. The RNAi‐based combined regulation strategy was applied to the three‐gene carotenoid pathway of Schizochytrium sp. and the nine‐gene docosahexaenoic acid (DHA) pathway of Yarrowia lipolytica, significantly enhancing the product production in both hosts. Integration of RNAi screening and dosage optimization further identified and tuned bypass pathways, increasing the ratio of DHA to docosapentaenoic acid (DPA) by 4.50‐fold versus wild type. These gains were maintained during 5‐L fermentation and serial passaging. This work establishes a compact and scalable regulatory framework for engineering complex biosynthetic pathways in eukaryotic microbial hosts.
SN - 2198-3844
ER -